Oral Session

Oral Session 3-7B Indolent lymphoma

Sun. Oct 14, 2018 9:40 AM - 10:40 AM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Yoichi Tatsumi (Deaprtment of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan)

+Add all to schedule

[OS3-7B-1] Long-term follow-up of 26 patients with MALT lymphoma with t(11;18)

Kosuke Toyoda¹, Akiko Maeshima², Junko Nomoto¹, Tomotaka Suzuki¹, Sayako Yuda¹, Nobuhiko Yamauchi¹, Hirokazu Taniguchi², Shinichi Makita¹, Suguru Fukuhara¹, Wataru Munakata¹, Dai Maruyama¹, Kensei Tobinai¹, Yukio Kobayashi^1,3 (1.Hematology, National Cancer Center Hospital, Tokyo, Japan, 2.Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan, 3.Hematology, IUHW, Mita Hospital, Tokyo, Japan)

[OS3-7B-2] Duodenal-type follicular lymphoma exhibits good prognosis through the increased anti-tumor immunity

Hiroaki Inoue, Shinya Rai, Takahiro Kumode, Serizawa Kentaro, Yasuhiro Taniguchi, Shoko Nakayama, Yasuyoshi Morita, Espinoza Luis, Hirokazu Tanaka, Yoichi Tatsumi, Takashi Ashida, Itaru Matsumura (Hematol. and Rheumatol., Kindai Univ., Osaka, Japan)

[OS3-7B-3] Clinicopathologic prognostic factors of follicular lymphoma (FL) patients under watch and wait (WW)

Sayako Yuda^1,2, Akiko Maeshima¹, Hirokazu Taniguchi¹, Yuta Ito¹, Shunsuke Hatta², Tomotaka Suzuki², Shinichi Makita², Suguru Fukuhara², Wataru Munakata², Tatsuya Suzuki², Dai Maruyama², Koji Izutsu² (1.Department of Pathology, National Cancer Center Hospital, Tokyo, Japan, 2.Department of Hematology, National Cancer Center Hospital, Tokyo, Japan)

[OS3-7B-4] MYC copy number predicts histologic transformation of follicular lymphoma to aggressive lymphoma

Maiko Kiryu¹, Keisuke Kawamoto¹, Takaharu Suzuki^1,2, Suguru Tamura¹, Syun Uemura¹, Akane Kaihatsu¹, Tatsuya Suwabe¹, Akira Imanishi¹, Takuya Kasami¹, Hiroki Nemoto¹, Takayuki Katagiri¹, Tomoyuki Tanaka¹, Ayako Nanba¹, Kyoko Fuse¹, Yasuhiko Shibasaki¹, Masayoshi Masuko¹, Hirohito Sone¹, Hiroaki Miyoshi², Masao Seto², Koichi Ohshima², Jun Takizawa¹ (1.Dpt.Hematology/Endocrinology/Metabolism,Niigata Univ.,Faculty of Medicine,Niigata,Japan, 2.Dpt. of Pathology, Kurume Univ., Kurume,Japan)

[OS3-7B-5] New assessment index for clinical transformation of follicular lymphoma in the rituximab era

Takafumi Shichijo¹, Dai Maruyama¹, Nobuhiko Yamauchi², Akiko Maeshima³, Masato Sugano⁴, Kinuko Tajima¹, Sayako Yuda¹, Tomotaka Suzuki¹, Kosuke Toyoda¹, Shinichi Makita¹, Suguru Fukuhara¹, Wataru Munakata¹, Tatsuya Suzuki¹, Yukio Kobayashi¹, Hirokazu Taniguchi³, Yosuke Minami², Koji Izutsu¹, Kensei Tobinai¹ (1.Hematology, National Cancer Center Hospital, Tokyo, Japan, 2.Hematology, National Cancer Center Hospital East, Kashiwa, Japan, 3.Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan, 4.Pathology, National Cancer Center Hospital East, Kashiwa, Japan)

[OS3-7B-6] Long-term follow-up results of patients with localized primary ocular adnexal malt lymphoma (OAL)

Ritsuko Nakai¹, Dai Maruyama¹, Akiko Miyagi Maeshima², Kinuko Tajima¹, Yuta Ito¹, Shunsuke Hatta¹, Sayako Yuda¹, Tomotaka Suzuki¹, Shinichi Makita¹, Suguru Fukuhara¹, Wataru Munakata¹, Tatsuya Suzuki¹, Jun Itami³, Shigenobu Suzuki⁴, Hirokazu Taniguchi², Yukio Kobayashi¹, Kensei Tobinai¹, Koji Izutsu¹ (1.Hematology, National Cancer Center Hospital, Tokyo, Japan, 2.Pathology, National Cancer Center Hospital, Tokyo, Japan, 3.Radiology, National Cancer Center Hospital, Tokyo, Japan, 4.Ophthalmology, National Cancer Center Hospital, Tokyo, Japan)